NRSN logo

NeuroSense Therapeutics Ltd. Ordinary Shares


NRSN: NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.


Show NRSN Financials

Consumer Interest
SEC Filings

Recent trades of NRSN by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by NRSN's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Methods and compositions of anti-inflammatory drug and dicer activator for treatment of neuronal diseases Apr. 20, 2021
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of NRSN in WallStreetBets Daily Discussion


Recent insights relating to NRSN

CNBC Recommendations

Recent picks made for NRSN stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in NRSN

Corporate Flights

Flights by private jets registered to NRSN